Skip to main content
SpringerLink
Log in

Author’s reply

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

No datasets were generated in the preparation of this manuscript.

References

  1. Heffernan AJ, Sime FB, Lim SMS et al (2022) Pharmacodynamics of ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus: is it a viable treatment option? Int J Antimicrob Agents 59(3):106537. https://doi.org/10.1016/j.ijantimicag.2022.106537

    Article  CAS  PubMed  Google Scholar 

  2. Zelenitsky SA, Beahm NP, Iacovides H, Ariano RE, Zhanel G (2018) Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis. J Antimicrob Chemother 73(7):1888–1894. https://doi.org/10.1093/jac/dky120

    Article  CAS  PubMed  Google Scholar 

  3. Carr DR, Stiefel U, Bonomo RA, Burant CJ, Sims SV (2018) A comparison of cefazolin versus ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia in a tertiary care VA medical center. Open Forum Infect Dis 5(5). https://doi.org/10.1093/ofid/ofy089

  4. Hamad Y, Connor L, Bailey TC, George IA (2020) Outcomes of outpatient parenteral antimicrobial therapy with ceftriaxone for methicillin-susceptible Staphylococcus aureus bloodstream infections—a single-center observational study. Open Forum Infect Dis 7(9). https://doi.org/10.1093/ofid/ofaa341

  5. Patel UC, McKissic EL, Kasper D et al (2014) Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible Staphylococcal aureus (MSSA) bloodstream infections. Int J Clin Pharm 36(6):1282–1289. https://doi.org/10.1007/s11096-014-9999-5

    Article  CAS  PubMed  Google Scholar 

  6. Barber KE, Cramer RA, Bell AM, Wagner JL, Stover KR (2021) Ceftriaxone as an alternative therapy for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia after initial clearance of bloodstream infection. Marangoni A, ed. Case Rep Infect Dis 2021:1–6. https://doi.org/10.1155/2021/8884685

    Article  Google Scholar 

  7. The European Committee on Antimicrobial Susceptibility Testin. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0, 2023.https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_%0A13.0_Breakpoint_Tables.pdf. Accessed 31 Mar 2023

  8. CLSI. M100 performance standards for antimicrobial susceptibility testing, 33rd Edition.Published 2023. https://clsi.org/standards/products/microbiology/documents/m100/. Accessed 31 Mar 2023

  9. Staphylococcus aureus bacteremia antibiotic treatment options (SABATO). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/results/NCT01792804?view=results. Accessed 31 Mar 2023

Download references

Author information

Authors and Affiliations

  1. Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Zachary A. Yetmar & Omar M. Abu Saleh

Authors
  1. Zachary A. Yetmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Omar M. Abu Saleh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the conception and writing of this work.

Corresponding author

Correspondence to Zachary A. Yetmar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yetmar, Z.A., Saleh, O.M.A. Author’s reply. Eur J Clin Microbiol Infect Dis 42, 797–798 (2023). https://doi.org/10.1007/s10096-023-04604-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04604-x

Search

Navigation